RESTON, Va., Aug. 18 The Mirixa Corporation is pleased to announce that Kerr Drug has signed a licensing agreement for MirixaEdge(SM), Mirixa's clinical application that supports the delivery of pharmacist-based patient care services, including Medication Therapy Management (MTM). Awarded a grant to support delivery of patient care services by community pharmacists, Kerr will be offering MTM services to the City of Charleston, SC and Charleston Water Works employees and will utilize MirixaEdge as the technology platform for this effort.
Kerr evaluated a number of MTM platforms to support the grant initiative. Central to the decision to partner with Mirixa was the robustness of the MirixaEdge application functionality. Rebecca W. Chater, RPh, MPH, FAPhA, Executive Vice President for Kerr Drug feels the MirixaEdge software with its programmatic approach to chronic disease management is in alignment with Kerr's focus on developing new clinical services. "In order to ensure consistency of clinical service delivery across our pharmacies, we need a tool like MirixaEdge to provide the framework for guiding an interactive discussion between the pharmacist and the patient. The MirixaEdge application has the right level of structure, along with disease-specific inquiries, that will be of great benefit to our customers and staff."
Kerr Drug will utilize the Mirixa technology to track the progress of employee medication regimens, to provide patient educational information, and to report on outcomes achieved through MTM service delivery. Kerr has established itself as a leader in providing pharmacist-supervised patient care services and this grant will help Kerr to further measure the reach of its programs.
Tony Civello, President & CEO of Kerr Drug views this initiative as another example of Kerr's drive to provide patients, health plans and the medical community with the most comprehensive and convenient health and wellness programs. "Our mission is to position the role of the pharmacist and the pharmacy as more than just a dispensing function. Pharmacists have extensive clinical knowledge that should be leveraged by patients to better understand their medications and how to take them. The MirixaEdge application will help us capture and ultimately measure the value our patients are receiving."
Mirixa is pleased to be joining forces with Kerr Drug in helping to improve the health of the employees of the City of Charleston and the Charleston Water Works. Rick Solano, CEO of Mirixa explains, "Kerr looked extensively at technology partners for this project and we are delighted with their selection of MirixaEdge. Kerr stores will join other forward- looking pharmacies that are using MirixaEdge as part of a patient-centric disease management program."
Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.
About Kerr Drug
Kerr Drug is one of the most recognized and respected names in the chain drug industry. With its roots in the Carolinas and headquarters in Raleigh, N.C., Kerr Drug's strategic direction is founded in its unique ability to provide patients, the medical community, and health plans access to the most comprehensive and convenient health and wellness offering in the industry. With a mission to be the most comprehensive provider of pharmacy and related healthcare services, while continuing to be the most reliable provider of health-related and convenience items, Kerr is currently providing services that far exceed the traditional drug store mix. For more information, please visit www.kerrdrug.com.
Media Contact: Mirixa: Anne Marie Heil 703.865.2035 [email protected]
SOURCE Mirixa Corporation